Breaking News Instant updates and real-time market news.

RHHBY

Roche

$0.00

(0.00%)

09:25
06/27/19
06/27
09:25
06/27/19
09:25

Wolfe Research pharma analyst to hold an analyst/industry conference call

Global Pharmaceuticals Analyst Anderson discusses Roche's pipeline on an Analyst/Industry conference call to be held on June 27 at 10 am.

  • 27

    Jun

  • 03

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

RHHBY Roche
$0.00

(0.00%)

06/11/19
JANY
06/11/19
NO CHANGE
JANY
Buy
uniQure weakness a buying opportunity, says Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong said he does not see any fundamental reason for today's weakness in shares of uniQure (QURE), attributing the pullback as likely due to profit taking following some recent strong performance. Roche's (RHHBY) deal to buy Spark Therapeutics (ONCE) in February had a positive impact on the overall gene therapy sector and investor speculation has contributed to an over 30% increase in uniQure shares over the past two weeks, noted Zhong, who said his valuation does not include any acquisition assumption or premium. The analyst, who sees uniQure having the first FDA approval for an AAV gene therapy for hemophilia B and the first AAV gene therapy program in the clinic for Huntington's disease, keeps a Buy rating on the stock and would be a buyer amid today's weakness.
06/20/19
DBAB
06/20/19
UPGRADE
DBAB
Buy
Roche upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Richard Parkes upgraded Roche to Buy from Hold saying the company's portfolio and pipeline should offset upcoming U.S. biosimilar launches. The analyst sees upside to consensus estimates.
06/20/19
LIBR
06/20/19
DOWNGRADE
LIBR
Hold
Roche downgraded to Hold from Buy at Liberum
Liberum analyst Graham Doyle downgraded Roche to Hold from Buy with a price target of 275 francs. The analyst says the shares are "no longer in bargain territory" and that there are a lack of catalysts to move them higher.
06/21/19
WBLR
06/21/19
NO CHANGE
WBLR
Outperform
William Blair an 'aggressive' buyer of Exelixis on weakness from clinical miss
William Blair analyst Andy Hsieh is an "aggressive" buyer of Exelixis (EXEL) shares on weakness after the company's partner Roche (RHHBY) informed the company that the Phase III IMspire170 trial, which assesses the safety and efficacy of the combination of Cotellic and Tecentriq, did not meet the primary endpoint of progression-free survival in treatment-naive melanoma. Hsieh says that while the news is disappointing, he reiterates that his bullish thesis resides in Exelixis's growth potential, driven by the Cabometyx franchise. As a result, the melanoma clinical setback does not impact the analyst's stock outlook. Further, he points out that he and the Street have not modeled revenue contribution from the IMspire170 study. Hsieh keeps an Outperform rating on Exelixis.

TODAY'S FREE FLY STORIES

CHEOY

Cochlear

$0.00

(0.00%)

05:20
07/17/19
07/17
05:20
07/17/19
05:20
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURBY

Burberry

$0.00

(0.00%)

05:18
07/17/19
07/17
05:18
07/17/19
05:18
Downgrade
Burberry rating change  »

Burberry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPI

SPI Energy

$2.26

0.03 (1.35%)

05:17
07/17/19
07/17
05:17
07/17/19
05:17
Hot Stocks
SPI Energy appoints Anthony Chan as CFO »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$129.75

-5.33 (-3.95%)

05:15
07/17/19
07/17
05:15
07/17/19
05:15
Downgrade
Lear rating change  »

Lear downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

NUS

Nu Skin

$45.50

1.44 (3.27%)

05:14
07/17/19
07/17
05:14
07/17/19
05:14
Downgrade
Nu Skin rating change  »

Nu Skin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CHAC

Chardan Healthcare

$9.81

(0.00%)

05:13
07/17/19
07/17
05:13
07/17/19
05:13
Hot Stocks
Chardan Healthcare announces merger agreement with BiomX »

Chardan Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVI

Levi Strauss

$19.81

-0.3 (-1.49%)

, RL

Ralph Lauren

$115.16

2.555 (2.27%)

05:11
07/17/19
07/17
05:11
07/17/19
05:11
Downgrade
Levi Strauss downgraded to Sell from Neutral at Goldman Sachs »

Goldman Sachs analyst…

LEVI

Levi Strauss

$19.81

-0.3 (-1.49%)

RL

Ralph Lauren

$115.16

2.555 (2.27%)

PVH

PVH Corp.

$92.50

2.08 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

CRZO

Carrizo Oil & Gas

$11.21

0.5 (4.67%)

05:11
07/17/19
07/17
05:11
07/17/19
05:11
Downgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$115.16

2.555 (2.27%)

05:08
07/17/19
07/17
05:08
07/17/19
05:08
Downgrade
Ralph Lauren rating change  »

Ralph Lauren downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

PVH

PVH Corp.

$92.50

2.08 (2.30%)

05:06
07/17/19
07/17
05:06
07/17/19
05:06
Downgrade
PVH Corp. rating change  »

PVH Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

PVH

PVH Corp.

$92.50

2.08 (2.30%)

05:06
07/17/19
07/17
05:06
07/17/19
05:06
Downgrade
PVH Corp. rating change  »

PVH Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SHLX

Shell Midstream

$21.52

0.32 (1.51%)

05:02
07/17/19
07/17
05:02
07/17/19
05:02
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$140.43

2.02 (1.46%)

05:00
07/17/19
07/17
05:00
07/17/19
05:00
Upgrade
Hershey rating change  »

Hershey upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SGEN

Seattle Genetics

$63.12

-0.87 (-1.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Upgrade
Seattle Genetics rating change  »

Seattle Genetics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Credit Suisse energy analysts to hold an analyst/industry conference call »

Analysts provide a 2Q…

KSHB

KushCo Holdings

$0.00

(0.00%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
KushCo Holdings management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

TELL

Tellurian

$7.68

-0.1 (-1.29%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Tellurian management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOVA

Dova Pharmaceuticals

$16.07

(0.00%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

CRD.B

Crawford & Company

$9.34

-0.13 (-1.37%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Crawford & Company management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

04:55
07/17/19
07/17
04:55
07/17/19
04:55
General news
Breaking General news story  »

Week of 7/12 MBA Mortgage…

PANW

Palo Alto Networks

$219.83

0.41 (0.19%)

, FTNT

Fortinet

$84.79

-0.19 (-0.22%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Analyst Seyrafi holds a…

PANW

Palo Alto Networks

$219.83

0.41 (0.19%)

FTNT

Fortinet

$84.79

-0.19 (-0.22%)

PFPT

Proofpoint

$126.33

0.61 (0.49%)

CHKP

Check Point

$116.24

-1.37 (-1.16%)

SAIL

SailPoint

$20.12

-0.27 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 01

    Aug

  • 06

    Aug

  • 21

    Aug

  • 21

    Aug

  • 13

    Nov

OVID

Ovid Therapeutics

$2.39

-0.19 (-7.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Ovid Therapeutics management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CLNE

Clean Energy

$2.75

-0.01 (-0.36%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Clean Energy management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

VFF

Village Farms

$9.29

-0.125 (-1.33%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Village Farms management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CASY

Casey's General Stores

$160.35

0.98 (0.61%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55
Conference/Events
Casey's General Stores management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.